Functional analysis of glycoproteins in tumor spheres
Project/Area Number |
20K07629
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Review Section |
Basic Section 50010:Tumor biology-related
|
Research Institution | Osaka International Cancer Institute |
Principal Investigator |
Ohkawa Yuki 地方独立行政法人大阪府立病院機構大阪国際がんセンター(研究所), その他部局等, 糖鎖オンコロジー部・研究員 (40723896)
|
Project Period (FY) |
2020-04-01 – 2023-03-31
|
Project Status |
Completed (Fiscal Year 2022)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2022: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2021: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2020: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
|
Keywords | 糖鎖 / がん / スフェロイド / N型糖鎖 / 糖タンパク質 |
Outline of Research at the Start |
幹細胞マーカーを発現するがん細胞は、がん幹細胞と呼ばれ、化学療法や放射線療法に強い抵抗性を示す。また、がん幹細胞の特性としてスフェロイドの形成(足場非依存的増殖)が知られており、スフェロイド形成の制御が新たながんの治療法として期待されている。本研究では、がんのスフェロイド形成を制御する糖タンパク質に注目し、その作用機構を明らかにする。またその糖タンパク質が、がんの治療に効果があるかどうかを検証する。
|
Outline of Final Research Achievements |
Fetuin-A: α-2-HS-glycoprotein, is secreted from the liver and can be detected in human blood. The function of Fetuin-A against cancer is not clear to date. In this study, we found that Fetuin-A increased cell growth rate and resistance in lung cancer cells against anti-cancer drug treatment. Additionally, we clarified a part of its molecular mechanisms.
|
Academic Significance and Societal Importance of the Research Achievements |
Fetuin-Aの癌に対する機能を世界に先駆けて明らかにした。またその作用メカニズムの一端を明らかにしたことから、Fetuin-Aを標的にした、新たな治療法の開発が期待される。
|
Report
(4 results)
Research Products
(37 results)
-
-
-
-
[Journal Article] Signaling domains of cancer-associated glycolipids. Tribute to Professor Sen-itiroh Hakomori2022
Author(s)
Furukawa, K., Ohmi, Y., Hamamura, K., Kondo, Y., Ohkawa, Y., Kaneko, K., Hashimoto, N., Farhana, Y., Bhuiyan, R.H., Tajima, O., Furukawa, K.
-
Journal Title
Glycoconj. J.
Volume: 39
Issue: 2
Pages: 145-155
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
[Journal Article] Lack of GD3 synthase (St8sia1) attenuates malignant properties of gliomas in genetically engineered mouse model.2021
Author(s)
Ohkawa, Y., Zhang, P., Momota, H., Kato, A., Hashimoto, N., Ohmi, Y., Bhuiyan, R.H., Natsume, A., Wakabayashi, T., Furukawa, K, Furukawa K.
-
Journal Title
Cancer Sci.
Volume: 112
Issue: 9
Pages: 3756-3768
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins.2021
Author(s)
Yesmin, F., Bhuiyan, R.H., Ohmi, Y., Yamamoto, S., Kaneko, K., Ohkawa, Y., Zhang, P., Hamamura, K., Cheung, N-K.V., Kotani, N., Honke, K., Okajima, T., Kambe, M., Tajima, O., Furukawa, K., Furukawa, K.
-
Journal Title
Int. J. Mol. Sci.
Volume: 23
Issue: 1
Pages: 423-442
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] St8sia1-deficiency in mice alters tumor environments of gliomas, leading to reduced disease severity2021
Author(s)
Zhang, P., Ohkawa, Y., Yamamoto, S., Momota, H., Kato, A., Kaneko, K., Natsume, A., Farhana, Y., Ohmi, Y., Okajima, T., Bhuiyan, R.H., Wakabayashi, T., Furukawa, K., Furukawa, K.
-
Journal Title
Nagoya Journal of Medical Science
Volume: 83
Issue: 3
Pages: 535-549
DOI
NAID
ISSN
0027-7622
URL
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
[Journal Article] Novel molecular mechanisms for roles of gangliosides in the nervous system elucidated by genetic engineering.2020
Author(s)
Furukawa, K., Ohmi, Y., Yesmin, F., Tajima, O., Kondo, Y., Pu Zhang, P., Hashimoto, N., Ohkawa, Y., Bhuiyan, R.H., Furukawa, K.
-
Journal Title
Int. J. Mol. Sci.
Volume: 21
Issue: 6
Pages: 1906-1906
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-